| Application no. and date | 17760400.6 (espacenet) (Federated) (European Patent Register), 20170228 | | Patent/reg. no. and date | DK/EP 3423061, 20240807 | | Publication date | 20190109 | | Priority no. and date | SE 1650274, 20160302, SE 1651204, 20160908 | | EP pub. no. and date |
EP 3423061 20190109 | | Effective date | | | Applicant/owner | Medivir Aktiebolag, P.O. Box 1086
141 22 Huddinge, SE | | Applicant ref. no. | | | Inventor | ALBERTELLA, Mark, C/o Medivir Ab
Box 1086
141 22 Huddinge, SE,
ENEROTH, Anders, C/o Medivir AB
Box 1086
141 22 Huddinge, SE,
KLASSON, Björn, C/o Medivir AB
Box 1086
141 22 Huddinge, SE,
ÖBERG, Fredrik, C/o Medivir AB
Box 1086
141 22 Huddinge, SE,
ÖHD, John, C/o Medivir AB
Box 1086
141 22 Huddinge, SE | | Representative | | | Opponent | | | IPC Class | A61K 31/44 (2006.01) , A61K 31/4412 (2006.01) , A61K 31/513 (2006.01) , A61K 31/675 (2006.01) , A61K 31/685 (2006.01) , A61P 35/00 (2006.01) | | Title | COMBINATION THERAPY WITH SORAFENIB OR REGORAFENIB AND A PHOSPHORAMIDATE PRODRUG OF TROXACITABINE | | Int. application no. | SE2017050186 | | Int. publication no. | WO2017151044 | | Related patent (certificate) | | | Status | Enhedspatent registreret | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
